Pediatric Neurology 53 (2015) e3

Contents lists available at ScienceDirect

Pediatric Neurology journal homepage: www.elsevier.com/locate/pnu

Letter to the Editor Response to Radcliffe et al.: I greatly appreciate the comments offered by Radcliffe and Newham1 to our original article.2 Neurological examination using the neuropathy symptom score and the neuropathy disability score are important bedside tools in clinics for early diagnosis of diabetic peripheral neuropathy. It has been reporteddas we found in our studydthat these tests may lack adequate sensitivity in early stages of neuropathies. The main goal in our study was to evaluate the prevalence of diabetic peripheral neuropathy in children and adolescence. I agree, and other studies have also reported, that the monofilaments have the highest sensitivity and specificity for the clinical diagnosis of pediatric diabetic peripheral neuropathy and in our follow-up study we are using fine monofilaments. Our purpose was to compare the

0887-8994/$ e see front matter Ó 2015 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.pediatrneurol.2015.03.020

results of monofilaments with the nerve conduction velocity results.

References 1. Radcliffe N, Newham B. The Validity of Neurological Evaluation in Diabetic Neuropathy. Pediatr Neurol. 2015;52:e1. 2. Höliner I, Haslinger V, Lutschg J, et al. Validity of the neurological examination in diagnosing diabetic peripheral neuropathy. Pediatr Neurol. 2013;49:171-177.

Isabella Walter-Höliner, MD Department of Pediatrics Academic Teaching Hospital Feldkirch, Austria E-mail address: [email protected]

Response to Radcliffe et al.

Response to Radcliffe et al. - PDF Download Free
125KB Sizes 0 Downloads 11 Views